Dr Emma Simpson BSc, PhD

HEDS, ScHARR
The University of Sheffield
Regent Court
30 Regent Street
Sheffield
S1 4DA
UK

Office:

Tel: (+44) (0)114 222 0708
Fax: (+44) (0)114 272 4095

E-mail: e.l.simpson@sheffield.ac.uk

Biography

I joined HEDS in 2005 and am a member of ScHARR-TAG.

Research interests

I have a PhD in psychology, and a background in health services research.

Current projects

I am currently working on the following projects. These projects are part of the Health Technology Assessment Programme, part of a 5 year contract to provide technology assessment reports to the Department of Health.

• Health Technology Assessment (07/08) Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin (Principal Investigator) (2007-8)
• Health Technology Assessment (07/35) Oseltamivir, amantadine and zanamivir for the prophylaxis of influenza (co-applicant, PI P. Tappenden) (2007-8)
• Health Technology Assessment (03/52) Thrombophilia testing (Principal investigator) (2006-7)
• Health Technology Assessment (06/27) Use of classical and novel biomarkers as prognostic risk factors for prostate cancer (co-applicant, PI P. Sutcliffe) (2007)
• Health Technology Assessment (06/18) Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation (co-applicant, PI Sue E. Ward) (2005-6)
• Health Technology Assessment (03/20) Hormonal therapies for early breast cancer: systematic review and economic evaluation (Co-applicant, PI Daniel Hind) (2005-6)
• Health Technology Assessment (08/01) Intensity modulated radiotherapy for breast cancer(Co-applicant, PI Sue Ward) (2008-9)
• Health Technology Assessment (08/01) Intensity modulated radiotherapy for head and neck cancer(Co-applicant, PI Alejandra Duenas) (2008-9)
• Health Technology Assessment (08/01) Intensity modulated radiotherapy for prostate cancer(Co-applicant, PI Silvia Hummel)

Key publications

• Ward SE, Simpson EL, Davis S, Hind D, Rees A, Wilkinson A. Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation. Health Technology Assessment (2007) 11(40):1-144
• Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L. Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technol Assess 2007;11(26).
• Developing partnerships for research: training workshops for mental health service users, carers and workers. Psychiatric Bulletin 2006;30:67-69, Simpson EL, Bryant LD, Ruddy R, and Atkin K [link]
• Simpson, E.L., Duenas, A., Holmes, M.W., Papaioannou, D. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin Health Technol Assess(in press)
• Simpson EL, Stevenson MD, Rawdin A, Papaioannou D. Thrombophilia testing. Health Technology Assessment(in press)
• Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R. Oseltamivir, amantadine and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67) Health Technol Assess(in press)